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Abstract
Background: Myocardial recovery after primary percutaneous coronary intervention in acute myocardial infarction
is variable and the extent and severity of injury are difficult to predict. We sought to investigate the role of
cardiovascular magnetic resonance T1 mapping in the determination of myocardial injury very early after treatment
of ST-segment elevation myocardial infarction (STEMI).
Methods: STEMI patients underwent 3 T cardiovascular magnetic resonance (CMR), within 3 h of primary percutaneous
intervention (PPCI). T1 mapping determined the extent (area-at-risk as %left ventricle, AAR) and severity (average T1
values of AAR) of acute myocardial injury, and related these to late gadolinium enhancement (LGE), and microvascular
obstruction (MVO). The characteristics of myocardial injury within 3 h was compared with changes at 24-h to predict
final infarct size.
Results: Forty patients were included in this study. Patients with average T1 values of AAR ≥1400ms within 3 h of
PPCI had larger LGE at 24-h (33% ±14 vs. 18% ±10, P = 0.003) and at 6-months (27% ±9 vs. 12% ±9; P < 0.001), higher
incidence and larger extent of MVO (85% vs. 40%, P = 0.016) & [4.0 (0.5–9.5)% vs. 0 (0–3.0)%, P = 0.025]. The average T1
value was an independent predictor of acute LGE (β 0.61, 95%CI 0.13 to 1.09; P = 0.015), extent of MVO (β 0.22, 95%CI
0.03 to 0.41, P = 0.028) and final infarct size (β 0.63, 95%CI 0.21 to 1.05; P = 0.005). Receiver-operating-characteristic
analysis showed that T1 value of AAR obtained within 3-h, but not at 24-h, predicted large infarct size (LGE > 9.5%)
with 100% positive predictive value at the optimal cut-off of 1400ms (area-under-the-curve, AUC 0.88, P = 0.006).
Conclusion: Hyper-acute T1 values of the AAR (within 3 h post PPCI, but not 24 h) predict a larger extent of MVO and
infarct size at both 24 h and 6months follow-up. Delayed CMR scanning for 24 h could not substitute the significant
value of hyper-acute average T1 in determining infarct characteristics.
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Background
One year mortality remains high at ~ 10% in patients
presenting with ST-segment elevation myocardial infarc-
tion (STEMI), despite emergency revascularisation by
primary percutaneous coronary intervention (PPCI) [1].
Early recognition of a high-risk subgroup may enable
patient selection for specific therapies to improve early
outcomes and reduce future risk [1, 2]. Existing ap-
proaches rely on recognition of adverse outcomes after
the acute phase of STEMI, when myocardial injury is
irreversible, are largely based on treating the “average”
patient and do not reflect tissue characteristics at an in-
dividual patient level [1, 2].
Cardiovascular magnetic resonance (CMR) is widely
used to characterise injured myocardium [3]. Ischaemic
and infarcted tissues are affected by oedema, necrosis,
haemorrhage and disruption of microvascular integrity
[3]. This complex tissue-level heterogeneity makes CMR
appealing for non-invasive characterisation of myocar-
dial injury after myocardial infarction [3]. Previous stud-
ies have demonstrated the utility of undertaking CMR
imaging 24–72 h after PPCI, and some as early as few
hours after myocardial infarction (MI) [4–6]. These
studies revealed imaging features most likely reflective of
the underlying dynamic tissue-level changes [4, 5]. Late
gadolinium enhancement (LGE) performed within 12 h
of STEMI is predictive of future adverse events beyond
traditional clinical risk factors such as age and diabetes
[7]. Whilst the quantification of myocardial injury de-
pends on the volume of myocardium subtended by the
artery beyond its occlusion and the ischaemia time,
other factors may have a significant impact on myocar-
dial recovery beyond the initial volumetric injury, such
as the duration and persistence of occlusion, the contri-
bution of collateral vessels, the effects of embolic debris,
release of vasoactive substances, reperfusion injury, and
myocardial oedema [8]. In a given patient, these individ-
ual variables cannot currently be ascertained with accur-
acy, nor can their effects be discerned in isolation. We
hypothesized that the integrated effect of these many
factors would be manifest very early (< 3 h) after PPCI
by direct tissue-level assessment using CMR, before the
‘secondary’ processes in myocardial injury, such a react-
ive oedema, had supervened [5, 6, 9]. Likewise, these
early changes may shed more light into the development
of certain pathophysiological processes within the in-
farcted region such as the development and progression
of microvascular obstruction and haemorrhage. An
advantage of such an approach would be the potential to
stratify patients to specific treatment pathways early
after PPCI, before irreversible myocardial injury had
occured [3].
Recently, native T1 mapping was demonstrated to re-
flect tissue composition, with changes in T1 relaxation
times reflecting pathological processes at the level of
myocardial tissue [10, 11]. Moreover, T1 mapping can
characterise injured myocardium, allowing assessments
of both severity of injury and potential for recovery [4,
10], making this technique ideally suited to the evalu-
ation and quantification of myocardial injury after
STEMI.
Accordingly, we designed a proof-of-concept study
using CMR T1 mapping for myocardial tissue character-
isation, to test whether very early CMR imaging, within
3 h after PPCI, could provide prospective useful informa-
tion to predict the evolution of myocardial injury, and
final infarct size, in STEMI patients.
Methods
Study population
Patients presenting with STEMI to the John Radcliffe
Hospital, Oxford who underwent PPCI for an occluded
coronary artery were prospectively enrolled as part of
the Oxford Acute Myocardial Infarction (OxAMI) pro-
ject (see Additional file 1) [4, 12]. This was a pre-
specified study within the OxAMI research programme,
and patients were prospectively recruited. These data
have not been reported in any other OxAMI published
studies [4, 12]. The study protocol was approved by the
local research ethics committee and conducted in ac-
cordance with the Declaration of Helsinki. All partici-
pants provided initial verbal assent followed by written
informed consent, in accordance with the approved
study protocol.
Cardiac magnetic resonance protocol
3 T CMR was performed (MAGNETOM Verio, Siemens
Healthineers, Erlangen, Germany) within 3 h of stent im-
plantation (hyper-acute), at 24 h (acute) and at 6 months
(follow-up). The scan protocol comprised cine balanced
steady state free precession (bSSFP) for functional im-
ages, native T1 mapping using the shortened modified
Look-Locker inversion recovery (ShMOLLI) for charac-
terisation of area-at-risk (AAR) [4, 11], T2* mapping for
intra-myocardial haemorrhage (IMH), and late gadolin-
ium enhancement (LGE).
Typical acquisition parameters for bSSFP retrospect-
ively gated cine images were TE / TR =1.4/3.2 ms; flip
angle 50°; voxel size: 2.4 × 1.8 × 8.0 mm. To shorten the
hyper-acute scan, the cine sequence at TP1 were ac-
quired in a single breath hold using real time electrocar-
diogram (ECG)-triggered and at lower resolution (160 ×
72) compared to other time points (224 × 137).
T2 weighted (T2w) was performed using a T2-prep-
bSSFP single shot sequence with surface coil correction
(TE/TR = 1/4.1 msec; effective TE = 60 msec; flip angle
90°; voxel size: 2.1 × 1.6 × 8.0 mm).
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ShMOLLI T1 maps were generated from 5 to 7 bSSFP
images with variable inversion preparation S2 time as
described previously [11]. Typical acquisition parameters
were: TE/TR = 1.07/2.14 msec, flip angle = 35°, FOV =
340 × 255mm, matrix size = 192 × 144, 107 phase encod-
ing steps, actual experimental voxel size = 1.8 × 1.8 × 8
mm, interpolated reconstructed voxel size = 0.9 × 0.9 × 8
mm, GRAPPA = 2, 24 reference lines, cardiac delay time
TD = 500msec and 206 msec acquisition time for single
image, phase partial Fourier 6/8.
T2* maps were obtained using a gradient echo se-
quence. Typical imaging parameters were: TR 600ms,
echo numbers (n = 5), TE 22.14 ms, FOV 340 × 225 mm,
bandwidth 5260 Hz/Px, matrix = 192 × 144, voxel size =
1.8 × 1.8 × 3.0 mm, flip angle 20°.
LGE was performed with a T1- weighted segmented in-
version recovery gradient echo-phase sensitive-inversion
recovery (GRE PSIR) sequence (TE/TR = 2.5 msec/5msec,
voxel size =1.8 × 1.4 × 8.0mm, flip angle 40°). LGE images
were collected 10–15min after the administration of 0.1
mmol/kg contrast agent (Dotarem, Guerbet, Villepinte,
France) [4]. The inversion time was adjusted for optimal
nulling of remote normal myocardium.
Hyper-acute T1 mapping was obtained from three
short axis slices targeting the regional wall motion ab-
normalities as assessed on functional images. This
protocol was specifically designed to minimise delays in
admission to the coronary care unit, given the hyper-
acute clinical setting of performing CMR immediately
after PPCI for STEMI.
CMR imaging analysis
Cvi42 image analysis software (Circle Cardiovascular
Imaging Inc., Calgary, Canada) was used by two experi-
enced operators in CMR image analysis. Left ventricular
(LV) volumes and ejection fraction (EF) were assessed
from cine bSSFP images. AAR on T1 mapping was iden-
tified similarly to previous reports using a threshold of
2SD above the mean value of remote reference region of
interest (ROI) placed 180 degrees opposite to the injured
myocardium with no visible regional wall abnormalities
or infarction (assessed by inspecting corresponding cine
and LGE images, respectively) [13]. T1 values of the
delineated area were subsequently averaged to assess the
severity of myocardial oedema, irrespective of the
presence of microvascular obstruction (MVO) (Fig. 1);
additionally, this area was measured as a percentage of
the LV mass (AAR).
LGE was depicted using signal intensity threshold set
at 5 standard deviations above the remote reference
myocardium [12]. When present, MVO was included in
the measurements of LGE. The LV MVO percentage
Fig. 1 Identification of area at risk (AAR) using cardiovascular magnetic resonance (CMR) T1 mapping. AAR was automatically delineated (pink
contour) using threshold of 2SD above the mean value of remote reference region of interest (ROI, contoured in blue) placed 180 degrees
opposite to the injured myocardium. This process was performed irrespective of presence of microvascular obstruction (MVO)
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fraction was quantified by manual delineation of the
hypointense areas within the LGE region [12]. IMH was
defined on T2* maps as a hypointense area within the
injured myocardium having a mean signal intensity 2SD
below the signal intensity of the periphery of
oedematous region and a mean T2* value < 20ms. Myo-
cardial salvage index (MSI) was calculated by subtracting
6 months %infarct size from 24 h %myocardial oedema
(derived from T1 mapping) and then divided by %myo-
cardial oedema at 24 h as previously described [4].
Patients with average T1 values > 1400 ms within AAR
were defined as high T1 value group. This threshold was
previously reported to discriminate reversible versus
irreversible myocardial injury using the same 3 T CMR
scanning platform and T1-mapping technique [4].
‘Large’ infarcts at 6 months were defined using a previ-
ously published cut-off of final infarct size of 9.5%,
derived from LGE, as a surrogate of long term clinical
outcomes [14].
Angiographic and electrocardiographic analysis
Angiographic analyses were performed offline by two ex-
perienced operators blinded to CMR parameters and
cases of disagreement were resolved by consensus. Final
thrombolysis in myocardial infarction (TIMI) flow and
post-procedural myocardial blush grade (MBG) were re-
corded [15]. Angiographic thrombus burden was graded
as previously described [15], and patients with thrombus
score of 5 were considered to have large thrombus bur-
den. Bystander coronary artery disease (CAD) in the
non-culprit artery was defined as > 50% luminal stenosis,
measured by two dimensional quantitative coronary
angiography (Medcon QCA software, Medcon Limited,
Tel Aviv, Israel) as previously described [12, 15].
A 12-lead ECG was recorded at admission and 60 min
after PPCI in all patients and ST resolution was defined
as more than 70% reduction in sum of ST-segments (see
Additional file 1).
Statistical analysis
Normality of distribution was assessed using the
Shapiro-Wilk test. All variables are expressed as mean ±
standard deviation or as median (IQR; interquartile
range) as appropriate. Frequency comparisons were
made using Chi-squared test or Fisher’s exact test, as
appropriate, whilst continuous variables were compared
by using unpaired Student’s t-test for parametric data or
Mann-Whitney U test for non-parametric data. A multi-
variate regression model was constructed to determine if
T1 value is an independent predictor of CMR measure-
ment (for every 10 ms increase in T1 values) after
adjustment for available clinical and angiographic char-
acteristics within 3 h of STEMI presentation. In order
not to overload the model, only variables with P < 0.05
on univariate analysis were entered. These variables in-
cluded age, gender, diabetes and hypertension status,
mean blood pressure at presentation, location of infarct
(anterior versus non-anterior) stent length and diameter,
use of glycoprotein IIb/IIIa inhibitors, TIMI and myo-
cardial blush grade at the end of procedure, thrombus
score, ST segment resolution, ischaemia time, door-to-
balloon time, troponin value, in addition to the extent of
injury as LV% (AAR) (no multi-collinearity was detected
on any model). All statistical analyses were performed
using SPSS 22.0 (Statistical Package for the Social
Sciences (SSPS), International Business Machines, Inc.,
Armonk, New York, USA) and a P value < 0.05 was
considered statistically significant.
Results
Forty STEMI patients (62 ± 11 years; 32 (82%) male)
underwent hyper-acute CMR within 3 h of PPCI.
Thirty (75%) patients were scanned at 24 h (acute)
and 29 (73%) patients came back for the 6-month
follow-up scan (Fig. 2). One patient had unevaluable
T1 mapping at the index CMR scan. The median is-
chemia time, defined from onset of chest pain until
restoration of coronary blood flow, was 183 min (IQR
153–301). Hyper-acute CMR scans were performed at
122 ± 55 mins after PPCI (median 112, IQR 73–151).
The average duration of CMR scanning was 33 ± 6
min.
Role of hyper-acute T1 value within AAR
There were no differences in clinical and procedural
characteristics, or time to CMR scanning between sub-
jects with AAR-T1 values ≥ or < 1400ms (Table 1).
There were significant differences in acute (24 h) CMR
parameters using the pre-specified 1400ms T1 cut-off
obtained at the hyper-acute scan. Patients with hyper-
acute T1>1400 ms in the injured myocardium had larger
LV end diastolic volume (LVEDV) (184 ± 30 vs. 154 ± 34
ml; P = 0.021), LGE myocardium (33% ±14 vs. 18% ±10;
P = 0.003), MVO incidence (85% vs. 40%; P = 0.016) and
extent of MVO [4.0 (0.5–9.5)% vs. 0 (0–3.0)%, P = 0.025]
(Table 2). These patients tended to have larger LV sys-
tolic volume (LVESV), incidence and extent of IMH, but
these did not reach statistical difference. There was no
difference in LV ejection fraction between two groups
(46% ±10 vs. 49% ±11; P = 0.44), or regression in extent
of LGE (7.3 ± 6.5% vs. 4.5 ± 3.8%, P = 0.12).
Similarly, LVEDV at follow-up CMR was larger (197 ±
49 vs. 159 ± 26 ml; P = 0.020) with a trend towards larger
LVESV (99 ± 40 vs. 74 ± 19ml, P = 0.050) in patients
with hyper-acute T1 values of AAR > 1400ms. Final
infarct size (27% ±9 vs. 12% ±9, P < 0.001) was also
larger while the myocardial salvage index was smaller
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(45% (37–54) vs. 71% (47–90), P = 0.021) (Table 3 and
Fig. 3).
Clinical features including age, gender, diabetes status,
infarct location, blood pressure on arrival, ischaemia
time, Killip-class on admission, or ECG parameters such
as presence of Q wave and QRS duration did not predict
infarct severity as determined by average T1 mapping.
Similarly, none of procedural characteristics including
thrombus score, use of glycoprotein IIb/IIIa inhibitors,
stent diameter and length reached statistical significance
to ascertain association with infarct severity.
At the hyper-acute time point, there was a significant
relationship between average T1 value and AAR (r =
0.66, P < 0.001).
Hyper-acute extent of injury (AAR) as predictors of acute
and follow-up CMR measurements
Univariate regression analysis revealed that hyper-acute
AAR was a predictor of acute LV volumes, extent of
LGE, MVO and IMH, in addition to LV ejection fraction
(Table 4). However, this association was lost when
adding other significant predictors such as the
angiographic-derived thrombus score and myocardial
blush grade for MVO and IMH extent. Hyper-acute
AAR remained a significant predictor of acute LV vol-
umes [EDV (β 1.21, 95% CI 0.15 to 2.28, P = 0.027) and
ESV (β 0.94, 95% CI 0.02 to 1.86, P = 0.046)], ejection
fraction (β − 0.31, 95% CI − 0.56 to − 0.07, P = 0.015) and
LGE (β 0.39, 95% CI 0.04 to 0.74, P = 0.029) (Table 4).
Similarly, hyper-acute AAR was a predictor of follow-
up LV volumes, ejection fraction, MSI and final infarct
size on univariate regression analysis. This prediction
remained significant for follow-up CMR measurements
except for LVEDV and MSI, when analysed by multivari-
ate regression analysis LVESV (β 0.86, 95% CI 0.04 to
1.67, P = 0.041), ejection fraction (β − 0.27, 95% CI − 0.51
to − 0.04, P = 0.023), final infarct size (β 0.47, 95% CI
0.22 to 0.72, P = 0.001) (Table 4).
Hyper-acute average T1 values of AAR as predictors of
acute and follow-up CMR measurements
Hyper-acute average T1 value of the AAR was a pre-
dictor of acute LV volumes, and the extent of LGE,
MVO and IMH on univariate regression analysis
(Table 5). On multivariate regression analysis (after in-
cluding AAR as LV%), the average T1 of AAR value was
an independent predictor of LGE myocardium (β 0.61,
95% CI 0.13 to 1.09; P = 0.015) and extent of MVO (β
0.22, 95% CI 0.03 to 0.41; P = 0.028) (Table 5). The aver-
age T1 value of AAR was not an independent predictor
of LVEDV or extent of IMH. Importantly, adding the
average T1 value of AAR to the model rendered AAR
(LV%) not significant in predicting acute LVEDV (β
Fig. 2 Study flow chart. Patients presenting with ST elevation myocardial infarction (STEMI) & occluded vessel were prospectively enrolled to have
a hyper-acute CMR imaging (within 3 h)
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Table 1 Clinical characteristics of recruited patients stratified by average T1 values within the area at risk (AAR) at 3 h after primary
percutaneous coronary intervention (PPCI)
Clinical characteristics Whole cohort AAR with average T1
value (< 1400ms) (n = 24)
AAR with average T1
value (≥1400 ms) (n = 15)
P value
Agea 62 ± 11 61 ± 12 62 ± 10 0.88
Male genderb 32 (82) 18 (75) 14 (93) 0.22
Body Surface Areaa 2.06 ± 0.20 2.04 ± 0.19 2.10 ± 0.22 0.35
Hypertensionb 15 (38) 11 (46) 4 (27) 0.23
Dyslipidaemiab 12 (31) 8 (33) 4 (26) 0.66
Active smokingb 13 (33) 8 (33) 5 (33) 1.00
Diabetesb 3 (8) 3 (13) 0 0.27
Ischaemia time (mins)c 183 (153–301) 166 (148–269) 229 (182–352) 0.09
Door-to-balloon time (mins)c 27 (18–43) 24 (14–38) 31 (24–66) 0.16
Systolic pressure (mmHg)a 126 ± 27 130 ± 25 118 ± 29 0.19
Diastolic pressure (mmHg)a 73 ± 16 73 ± 15 73 ± 18 0.93
Anterior infarctb 11 (28) 5 (21) 6 (40) 0.20
Number of diseased vesselsc 1 (1–2) 1 (1–2) 1 (1–2) 0.94
Bystander diseaseb 15 (38%) 9 (38%) 6 (40%) 0.88
Large thrombus burdenb 18 (46%) 10 (42%) 8 (53%) 0.48
Thrombectomy useb 22 (56) 14 (58) 8 (53) 0.76
GP IIb/IIIab 6 (27) 3 (13) 3 (20) 0.66
Stent length (mm)a 31 ± 13 34 ± 15 26 ± 8 0.07
Stent diameter (mm)c 3.5 (3.0–4.0) 3.5 (3.1–4.0) 3.5 (3.0–4.0) 0.24
Final TIMI III flowb 28 (72) 19 (79) 9 (60) 0.20
MBG 2/3b 24 (62%) 16 (67%) 8 (53%) 0.41
Time to CMR (mins)a 122 ± 55 120 ± 58 125 ± 51 0.79
ST resolutionb 9 (23%) 5 (21%) 4 (27%) 0.67
Large thrombus burden was defined thrombus score ≥ 4. There was no difference in baseline clinical and procedural characteristics in those with or without 6
months follow up
a(mean ± SD), b(n, %), c (median, IQR)
Table 2 Acute (24 h) CMR characteristics stratified by average T1 values within the AAR at 3 h after PPCI
Acute CMR characteristics Whole cohort AAR with average T1 value
(< 1400ms) (n = 17)
AAR with average T1 value
(≥ 1400 ms) (n = 13)
P value
LV end diastolic volume (ml)b 168 ± 35 154 ± 34 184 ± 30 0.021
LV end systolic volume (ml)b 89 ± 31 80 ± 33 99 ± 26 0.103
LV ejection fraction (%)b 48 ± 10 49 ± 11 46 ± 10 0.442
Area at risk (%)b 40 ± 12 34 ± 6 48 ± 12 0.002
LGE myocardium (%)b 25 ± 14 18 ± 10 33 ± 14 0.003
MVO incidencea, c 17 (61) 6 (40) 11 (85) 0.016
MVO extent (%)d 1 (0–6.5) 0 (0–3.0) 4.0 (0.5–9.5) 0.025
IMH incidencea, c 15 (54) 6 (40) 9 (69) 0.122
IMH extent (mm2)d 0.76 (0–2.03) 0 (0–1.40) 0.76 (0–4.21) 0.152
IMH Intramyocardial haemorrhage, LGE Late gadolinium enhancement, LV Left ventricular, MVO Microvascular obstruction
aTwo patients with poor LGE and T2* mapping images were excluded from the analysis. b(mean ± SD), c(n, %), d(median, IQR)
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0.78, 95% CI − 0.53 to 2.09, P = 0.23) or LGE (β 0.15,
95% CI − 0.21 to 0.52, P = 0.39).
Hyper-acute average T1 value of the AAR predicted
follow-up LV volumes, EF, MSI and final infarct size
(Table 5). On multivariate regression analysis, the
average T1 value of AAR was an independent pre-
dictor of follow-up LV volumes (β 3.07, 95% CI 1.11
to 5.02; P = 0.003 for LVEDV) and (β 1.76, 95% 0.35
to 3.17; P = 0.016 for LVESV), MSI (β − 1.13, 95% CI
− 2.06 to − 0.19; P = 0.021) and final infarct size (β
0.65, 95% CI 0.25, 1.05; P = 0.003) (Table 5). Remark-
ably, AAR (LV%) did not remain significant when
adding average T1 value of AAR to the model in pre-
dicting LVESV (β 0.16, 95% CI − 0.78 to 1.09, P =
0.73), ejection fraction (β − 0.24, 95% CI − 0.54 to
0.07, P = 0.12) or final infarct size (β 0.21, 95% CI −
0.05 to 0.48, P = 0.11) at 6 months follow-up.
T1 value threshold to predict large final infarct size
Using the previously published cut-off of follow-up in-
farct size of 9.5% as a surrogate of long term clinical out-
comes [14], receiver-operating characteristics (ROC)
analysis using hyper-acute average T1 values of AAR (at
Table 3 CMR characteristics at 6 months stratified by average T1 values within the AAR at 3 h after PPCI
FU CMR characteristics Whole cohort AAR with average T1 value
(< 1400ms) (n = 16)
AAR with average T1 value
(≥ 1400ms) (n = 13)
P value
LV end diastolic volume (ml)a 175 ± 42 159 ± 26 197 ± 49 0.020
LV end systolic volume (ml)a 86 ± 32 74 ± 19 99 ± 40 0.050
LV ejection fraction (%)a 52 ± 8 53 ± 9 51 ± 8 0.494
MSI (%)b 50 (39–71) 71 (47–90) 45 (37–54) 0.021
Final infarct size (%)a 19 ± 11 12 ± 9 27 ± 9 < 0.001
Large infarctc 20 (69%) 7 (44%) 13 (100%) 0.001
a(mean ± SD), b (median, IQR), c(n, %)
Fig. 3 Myocardial T1 value and AAR to predict final infarct size. An example of two patient presenting with anterior STEMI with comparable AAR.
Hyper-acute T1 mapping was used to quantify AAR and infarct severity. Despite a relatively similar AAR (LV%), patients with less-elevated average
T1 value within the AAR (< 1400 ms; top row) had smaller final infarct sizes at 6 months compared to patients with higher T1 values within the
AAR (≥1400ms)
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3 h post PPCI) demonstrated an area under curve
(AUC) = 0.88, P = 0.006. By contrast, acute average T1
values of AAR (at 24 h post PPCI) did not predict large
follow-up infarct size (AUC = 0.57, P = 0.64) (Fig. 4).
The optimal threshold for the hyper-acute average
T1 value of AAR to predict large infarct size was
1396 ms, which was very similar to the value used to
divide this cohort based on a previously published
value of 1400 ms. [4] Using this threshold, average T1
value had a positive predictive value of 100% to pre-
dict large infarct size while its negative predictive
value was 60%. The specificity and sensitivity of this
threshold were 100 and 70%, respectively.
Discussion
This is the first prospective study to evaluate the value
of determining the severity of injured myocardium at a
very early time point (median time < 2 h after reperfu-
sion) in STEMI patients undergoing PPCI. The key find-
ings of this study are: (1) Hyper-acute average T1 values
of AAR were associated with infarct characteristics,
whereby patients with higher average T1 values (> 1400
Table 4 AAR (%LV) as a predictor of acute and follow-up CMR outcomes
Extent of injury Univariate regression analysis Multivariate regression analysisb
β Coefficient 95% CI P value β Coefficient 95% CI P value
Acute CMR (24 h) EDV 1.21 0.15,2.28 0.027 1.21a 0.15,2.28 0.027
ESV 1.53 0.72,2.34 0.001 0.94 0.02,1.86 0.046
EF −0.57 −0.81,-0.32 < 0.001 − 0.31 − 0.56,− 0.07 0.015
LGE% 0.76 0.39,1.12 < 0.001 0.39 0.04,0.74 0.029
MVO extent 0.23 0.07,0.38 0.006 0.07 -0.07,0.20 0.336
IMH extent 0.07 0,0.15 0.039 0.03 −0.04,0.11 0.362
Follow-up CMR
(6 months)
EDV 1.23 0.04,2.42 0.043 0.54 −0.66,1.74 0.361
ESV 1.24 0.39,2.08 0.006 0.86 0.04,1.67 0.041
EF −0.32 −0.53,-0.1 0.006 −0.27 −0.51,-0.04 0.023
MSI −0.88 −1.52,-0.23 0.010 −0.43 −1.15,0.30 0.235
Final infarct size 0.57 0.32,0.83 < 0.001 0.47 0.22,0.72 0.001
aNone of the variables in the model was a predictor of EDV (average T1 value of AAR was not included), bFor all CMR outcomes, adjustment was made for the
following variables: age, gender, diabetes and hypertension status, mean blood pressure at presentation, location of infarct (anterior versus non-anterior) stent
length and diameter, use of glycoprotein IIb/IIIa inhibitors, TIMI and myocardial blush grade at the end of procedure, thrombus score, ST segment resolution,
ischaemia time
Table 5 Hyper-acute average T1 value of injured myocardium as a predictor of acute and follow-up CMR outcomes
Severity of injury Univariate regression analysis Multivariate regression analysisa
Β Coefficient 95% CI P value β Coefficient 95% CI P value
Acute CMR (24 h) EDV 1.70 0.18,3.22 0.030 1.05 −0.82,2.91 0.260
ESV 1.34 −0.01,2.68 0.052 – – –
EF −0.34 −0.80,0.12 0.141 – – –
LGE% 1.06 0.54,1.59 < 0.001 0.61 0.13,1.09 0.015
MVO extent 0.35 0.14,0.57 0.002 0.22 0.03,0.41 0.028
IMH extent 0.11 0.01,0.21 0.031 0.08 −0.04,0.19 0.185
Follow-up CMR (6 months) EDV 3.00 1.32,4.47 0.001 3.00 0.60,5.37 0.017
ESV 2.32 1.15,3.51 < 0.001 1.76 0.35,3.17 0.016
EF −0.41 −0.78,-0.03 0.035 −0.09 −0.55,0.36 0.681
MSI −1.5 −2.41,-0.60 0.002 −1.13 −2.06,-0.19 0.021
Final infarct size 0.99 0.62,1.36 < 0.001 0.65 0.25,1.05 0.003
aFor all CMR outcomes, adjustment was made for the following variables: age, gender, diabetes and hypertension status, mean blood pressure at presentation,
location of infarct (anterior versus non-anterior) stent length and diameter, use of glycoprotein IIb/IIIa inhibitors, TIMI and myocardial blush grade at the end of
procedure, thrombus score, ST segment resolution, ischaemia time, door-to-balloon time, troponin value, in addition to the extent of injury as LV% (AAR)
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ms) had a larger extent of MVO and larger infarct size
at both 24 h and 6months follow-up; (2) hyper-acute
average T1 value within the AAR, but not the extent
(LV%) of AAR, independently predicted acute LGE myo-
cardium and final infarct size at 6 months; (3) the signifi-
cant value of hyper-acute average T1 value of AAR
could not be substituted by delaying scan for 24 h and
the utility of average T1 value exists only when CMR is
performed at very early time point post STEMI.
Tools to identify patients at increased risk post STEMI
are needed for prognostic and therapeutic purposes, in
addition, to guide clinical pathways and safe resource al-
location [1]. Our study demonstrated the potential role
of hyper-acute T1 values as a determinant of infarct
characteristics and a predictor of large infarct size during
both the acute and follow up settings. Importantly, the
role of T1 values was related to the timing of CMR im-
aging, which was performed immediately following re-
perfusion therapy following PPCI (median time < 2 h).
The higher the average T1 value of the AAR, the more
likely the patient was to sustain more severe injury irre-
spective of the initial volume of injury. The hyper-acute
phase post STEMI is critical in the evolution of acute
MI and early characterisation may allow for future
selection of specific targeted therapies [3]. T1 mapping
could provide an opportunity to risk stratify patients ac-
cording to their predicted final infarct size at a very early
stage enabling patient selection for trials to precisely as-
sess the effectiveness of new interventions.
Notably, the ability of T1 mapping to differentiate high
risk patients did not persist following the hyper-acute
time point. Indeed, T1 value of AAR did not predict
acute infarct size when obtained 24 h post STEMI. This
may be related to inter-individual variations in the re-
sponse to acute ischaemia and reperfusion, in addition
to the dynamic changes of the severity of injured myo-
cardium post reperfusion therapy [5, 9]. Human and ani-
mal models have demonstrated that the severity of
injured myocardium has a bimodal phenomenon with
the nadir at 24 h [5, 6, 9]. Furthermore, the emergence
of an infarct core, detected using T1 mapping may have
also contributed to the varied ability of using T1 values
alone to assess the severity and prognosis of acute myo-
cardial injury [13]. The hypo-intense infarct core identi-
fied using T1 mapping (typically seen as a “step-down”
in T1 values within the AAR) was reported in 56% of pa-
tients after 1–2 days post STEMI [13]. In these cases, the
apparently intuitive concept that “the higher the T1
Fig. 4 The ability of hyper-acute and acute average T1 value of AAR to predict large infarct size. The ability of using T1 values within the AAR to
predict large infarct size was related to the hyper-acute timing of performing CMR imaging (within 3 h post-primary percutaneous coronary
intervention (PPCI)). At 24 h, T1 value of AAR was not a predictor of large infarct size
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values, the more severe the injury” does not always hold
true, and illustrates the complexity of using T1 values
alone to predict outcomes in the presence of MVO and/
or IMH at 24 h post MI. Our study highlighted the dif-
ferential effect of timing when using native T1 mapping
in stratifying patients following STEMI. The lack of as-
sociation between average T1 value of the AAR at 24 h
and standard infarct characteristics at both 24 h and 6
months suggest that these imaging biomarkers may re-
flect distinct (but likely overlapping) tissue changes in
early infarct evolution; whether T1-AAR at 24 h provides
added value to standard CMR indices in infarct
characterization or prediction of outcomes awaits fur-
ther research.
Different imaging biomarkers have been proposed to
stratify STEMI patients, including LGE myocardium and
MSI [7, 16]. However, the prognostic role of these
biomarkers was dependent merely on the percentage size
of the LV affected and ignored the potential role of
within-tissue heterogeneity. The accuracy and clinical
application of acute LGE, and subsequently MSI, have
been challenged [3, 17]. Acute gadolinium-based param-
eters overestimate the necrotic myocardium because of
the increased extracellular space in the peri-infarct area,
assigning potentially low risk subjects into high risk
group [3, 17]. Recently, a large data-pooled meta-
analysis demonstrated a significant association between
mortality and MVO [18]. This relationship remained sig-
nificant after adjusting for infarct size and highlighting
the importance of infarct composition on long term out-
comes [18]. Importantly, MVO in that analysis was
quantified, on average, 3 days after STEMI when patients
are typically discharged, making its application for guid-
ing clinical decisions less useful. Moreover, the need to
administer contrast agent and to wait for it to distribute
within the myocardium limits the potential for applica-
tion of MVO at very early time post-STEMI.
Native T1 mapping can provide a quantitative assess-
ment of myocardial tissue composition in the setting of
acute STEMI, without the need for contrast agents [4,
10]. The technique has the potential to assess severity of
reperfusion injury or effectiveness of reperfusion treat-
ment early after the event and might be used to assess
measures aimed at reducing reperfusion injury.. Previous
experimental work demonstrated that T1 values were re-
lated to the duration of ischaemia reflecting changes of
intra- and extracellular environments within the myocar-
dium [19]. Mechanistically, the increase in T1 values is
largely related to the increase in tissue water content in
response to acute ischaemic insult [10, 19]. Following
STEMI, the processes that dictate infarct progression;
such as myocyte death, degradation of extracellular
matrix and microvascular dysfunction, are potentially
detectable on T1 mapping [4, 10]. Clinical or procedural
characteristics were not related to infarct severity, as
measured by T1 value within the injured myocardium.
Importantly, T1 mapping was performed after PCI and
therefore it is not possible to delineate effects of initial
infarct severity from reperfusion injury following PCI.
Future studies may identify additional clinical or proced-
ural characteristics that would influence the temporal
changes in T1 values. Early characterisation may provide
insights of myocardial potential of recovery, even before
primary PCI in very selected population [8].
Infarct size and ejection fraction are considered as sur-
rogates of infarct severity, nonetheless, their relationship
with hyper-acute T1 value was not similar. The lack of
correlation between ejection fraction and infarct size in
non-large infarcts suggest a complex interaction between
these two imaging biomarkers and may explain their as-
sociation with T1 value [20]. IMH was also not statisti-
cally different between high and low T1 values groups.
This may be related to the timing of 24 h CMR to quan-
tify IMH as IMH has been reported to peak 3 days post
STEMI [21].
Limitations
The sample size in our study is relatively small and the
implications for clinical outcomes cannot be derived
from a study of 40 patients. Early CMR imaging assess-
ment precludes high risk and hemodynamically unstable
patients. Those patients were excluded from our study,
nonetheless, they have already declared themselves as
high risk individuals and so stratification with imaging is
less pressing. CMR analysis was performed using a
threshold of 2SD for AAR and 5SD for LGE. While these
image post-processing approaches are endorsed by ex-
pert consensus from the Society for Cardiovascular Mag-
netic Resonance (SCMR) [22], the SD methodology is
sensitive to a number of factors, including the chosen
threshold, susceptibility to spatial variations in surface
coil sensitivity and the relative signal-to-noise ratio, and
whether remote myocardium is also affected by the
acute myocardial injury. Additionally, infarct-size quanti-
fication may vary depending on contrast agent type, dose
and timing after injection, as well as the timing early
after acute MI. Quantitative mapping techniques are
highly dependent on the sequence used, magnetic field
strength, and CMR hardware and software parameters.
Threshold-based image analysis approaches, especially
for novel mapping techniques, may eliminate the need
for reference ROIs, although standardization of these
quantitative techniques is an active area of research.
Overall, in the setting of acute MI when infarct evolu-
tion is dynamic, it is important to describe the methods
of image analysis and recognise the known limitations in
quantification of infarct size and AAR in this setting.
Additionally, T1 mapping analysis was based on the
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average of voxel-derived T1 value and irrespective on
presence of T1 core or MVO. This may have diminished
the ability of using T1 values to assess the severity of
acute myocardial injury, but it was a simple approach
that does not require extensive post processing. Future
efforts for advanced T1-map image analysis may facili-
tate more streamlined and standardized image analysis
approaches suitable for large clinical outcome trials.
Conclusion
Hyper-acute T1 values of the AAR (within 3 h post
PPCI, but not 24 h) predicted a larger extent of MVO
and infarct size at both 24 h and 6months follow-up.
Delaying CMR scanning for 24 h could not substitute
the significant value of hyper-acute average T1 in deter-
mining infarct characteristics.
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